Inflammation-Immunity-Nutrition Score: A Novel Prognostic Score for Patients with Resectable Colorectal Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Leuzzi G, Galeone C, Gisabella M, et al. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis. Tumori. 2016;102(5):441–449. doi:10.5301/tj.5000522
   PubMed Web of Science ®Google Scholar
• Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23(1):50. doi:10.1186/s12199-018-0740-1
   PubMed Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. doi:10.1161/01.CIR.0000052939.59093.45
   PubMed Web of Science ®Google Scholar
• Ostroumov D, Fekete-Drimusz N, Saborowski M, Kühnel F, Woller N. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol Life Sci. 2018;75(4):689–713. doi:10.1007/s00018-017-2686-7
   PubMed Web of Science ®Google Scholar
• Lu J, Xu BB, Zheng ZF, et al. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized Phase III trial. Gastric Cancer. 2019;22(3):536–545. doi:10.1007/s10120-018-0892-0
   PubMed Web of Science ®Google Scholar
• Li Y, Zhong X, Cheng G, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis. 2017;259:75–82. doi:10.1016/j.atherosclerosis.2017.02.003
   PubMed Web of Science ®Google Scholar
• Wilhelmsen M, Christensen IJ, Rasmussen L, et al. Detection of colorectal neoplasia: combination of eight blood-based, cancer-associated protein biomarkers. Int J Cancer. 2017;140(6):1436–1446. doi:10.1002/ijc.30558
   PubMed Web of Science ®Google Scholar
• Wei Y, Xu H, Dai J, et al. Prognostic significance of serum lactic acid, lactate dehydrogenase, and albumin levels in patients with metastatic colorectal cancer. Biomed Res Int. 2018;2018:1804086. doi:10.1155/2018/1804086
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15(7):405–414. doi:10.1038/nri3845
   PubMed Web of Science ®Google Scholar
• Bodén S, Myte R, Harbs J, et al. C-reactive protein and future risk of clinical and molecular subtypes of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1482–1491. doi:10.1158/1055-9965.EPI-19-1339
   PubMed Web of Science ®Google Scholar
• Ghuman S, Van Hemelrijck M, Garmo H, et al. Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer. 2017;116(10):1358–1365. doi:10.1038/bjc.2017.96
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Sakamoto Y, Nakagawa S, et al. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. Int J Clin Oncol. 2017;22(4):740–748. doi:10.1007/s10147-017-1102-5
   PubMed Web of Science ®Google Scholar
• Zheng C, Liu S, Feng J, Zhao X. Prognostic value of inflammation biomarkers for survival of patients with neuroblastoma. Cancer Manag Res. 2020;12:2415–2425. doi:10.2147/CMAR.S245622
   PubMed Web of Science ®Google Scholar
• Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Bone Joint J. 2015;97-B(6):847–852. doi:10.1302/0301-620X.97B.35098
   PubMedGoogle Scholar
• Takeno S, Hashimoto T, Shibata R, et al. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology. 2014;87(4):205–214. doi:10.1159/000362601
   PubMed Web of Science ®Google Scholar
• Yang JR, Xu JY, Chen GC, et al. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. Sci Rep. 2019;9(1):8143. doi:10.1038/s41598-019-44653-x
   PubMed Web of Science ®Google Scholar
• Luvián-Morales J, González-Trejo S, Carrillo JF, et al. Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: a STROBE compliant retrospective cohort study. Cancer Med. 2019;8(7):3379–3388. doi:10.1002/cam4.2212
   PubMed Web of Science ®Google Scholar
• Huang J, Xu L, Luo Y, He F, Zhang Y, Chen M. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy. Med Oncol. 2014;31(4):883. doi:10.1007/s12032-014-0883-x
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Shimodaira S, Nagai K, et al. Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis. Cancer Immunol Immunother. 2014;63(8):797–806. doi:10.1007/s00262-014-1554-7
   PubMed Web of Science ®Google Scholar
• Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–6272. doi:10.3748/wjg.v23.i34.6261
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Woo Y, Hyung WJ, Obama K, et al. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. J Surg Oncol. 2012;105(4):405–409. doi:10.1002/jso.22129
   PubMed Web of Science ®Google Scholar
• Di Stefano AL, Picca A, Saragoussi E, et al. Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions. Neuro Oncol. 2020;22(11):1614–1624. doi:10.1093/neuonc/noaa121
   PubMed Web of Science ®Google Scholar
• Hou X, Wang D, Zuo J, et al. Development and validation of a prognostic nomogram for HIV/AIDS patients who underwent antiretroviral therapy: data from a China population-based cohort. EBioMedicine. 2019;48:414–424. doi:10.1016/j.ebiom.2019.09.031
   PubMed Web of Science ®Google Scholar
• Luo Q, Chen D, Fan X, Fu X, Ma T, Chen D. KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: a single-site report. Transl Oncol. 2020;13(12):100874. doi:10.1016/j.tranon.2020.100874
   PubMed Web of Science ®Google Scholar
• Zhou ZQ, Pang S, Yu XC, et al. Predictive values of postoperative and dynamic changes of inflammation indexes in survival of patients with resected colorectal cancer. Curr Med Sci. 2018;38(5):798–808. doi:10.1007/s11596-018-1946-6
   PubMed Web of Science ®Google Scholar
• Tsuchihashi K, Ito M, Moriwaki T, et al. Role of predictive value of the modified Glasgow prognostic score for later-line chemotherapy in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2018;17(4):e687‐e697. doi:10.1016/j.clcc.2018.07.004
   PubMed Web of Science ®Google Scholar
• You W, Sheng N, Yan L, et al. The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers. J Cancer. 2019;10(16):3757–3766. doi:10.7150/jca.31660
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Okabayashi K, Hasegawa H, et al. Comparison of preoperative inflammation-based prognostic scores in patients with colorectal cancer. Ann Surg. 2018;267(3):527‐531. doi:10.1097/SLA.0000000000002115
   Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36(3):995–1001.
   PubMed Web of Science ®Google Scholar
• Sato R, Oikawa M, Kakita T, et al. The prognostic value of the prognostic nutritional index and inflammation-based markers in obstructive colorectal cancer. Surg Today. 2020;50(10):1272–1281. doi:10.1007/s00595-020-02007-5
   PubMed Web of Science ®Google Scholar